Back to search

Article

SARS-CoV-2 Vaccine Non-response among Hematopoietic Stem Cell Transplant Patients: A Systematic Review and Meta-analysis

2023-09-27

Abstract excerpt

<h4>Background: </h4> Hematopoietic stem cell transplant (HSCT) recipients are uniquely vulnerable to adverse outcomes of SARS-CoV-2 infection. Small, mostly observational studies suggest that some HSCT recipients may not generate protective antibody responses following SARS-CoV-2 vaccination. We conducted a meta-analysis to estimate the prevalence and identify predictors of vaccine non-response. Methods A compre...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d2d53e92-97c3-524e-b5b8-07c1c276f6f8
DOI
10.21203/rs.3.rs-3283799/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SARS-CoV-2 Vaccine Non-response among Hematopoietic Stem Cell Transplant Patients: A Systematic Review and Meta-analysisDOI 10.21203/rs.3.rs-3283799/v1
Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population; A systematic review and meta-analysisSemantic proximity
Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell TherapySemantic proximity
Alternative Strategies to Increase the Immunogenicity of Covid-19 Vaccines in Kidney Transplant Recipients Not Responding to Two or Three Doses of an mRNA Vaccine. A Randomized Clinical TrialSemantic proximity
SARS-CoV-2 T-Cell Responses in Allogeneic Hematopoietic Stem Cell Recipients following Two Doses of BNT162b2 mRNA VaccineSemantic proximity
Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patientsSemantic proximity
B and T cell responses after a third dose of SARS-CoV-2 vaccine in Kidney Transplant RecipientsSemantic proximity
Vaccine serologic responses among transplant patients associate with COVID-19 infection and T peripheral helper cellsSemantic proximity
HUMORAL AND CELLULAR IMMUNOGENICITY and SAFETY UP TO 4 MONTHS AFTER VACCINATION WITH BNT162B2 mRNA COVID-19 VACCINE IN HEART AND LUNG TRANSPLANTED YOUNG ADULTSSemantic proximity
A Phase I/II Study of Adoptive SARS-CoV-2 Specific T Cells in Immunocompromised Hosts with or at Risk of Severe COVID-19 InfectionSemantic proximity
Comparative immunogenicity of heterologous versus homologous 3rd SARS-CoV-2 vaccine doses in kidney transplant recipientsSemantic proximity
Humoral immune responses against SARS-CoV-2 variants including omicron in solid organ transplant recipients after three doses of a COVID-19 mRNA vaccineSemantic proximity
A systematic review assessing the effectiveness of COVID-19 mRNA vaccines in chronic kidney disease (CKD) individualsSemantic proximity
Select a neighboring publication to make it the new centre.